Retour
Fourchette du Jour
18,24 €
19,31 €
Fourchette 52 Semaines
14,69 €
30,81 €
Volume
897 357
Moyenne 50J / 200J
18,84 €
/
22,58 €
Clôture Précédente
18,51 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,7 | 0,3 |
| P/B | 2,7 | 2,9 |
| ROE % | -21,7 | 3,7 |
| Net Margin % | -33,6 | 3,8 |
| Rev Growth 5Y % | 1,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
21,95 €
+15.7%
Low: 13,00 €
High: 30,75 €
P/E Prévisionnel
822,7
BPA Prévisionnel
0,02 €
Croissance BPA (est.)
+0,0%
CA Est.
260 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,21 €
1,03 € – 1,33 €
|
410 M | 2 |
| FY2029 |
0,61 €
0,18 € – 1,44 €
|
340 M | 6 |
| FY2028 |
0,57 €
0,25 € – 0,86 €
|
320 M | 5 |
Points Clés
Revenue grew 0,96% annually over 5 years — modest growth
Debt/Equity of 0,11 — conservative balance sheet
Negative free cash flow of -40,05M
Revenue growth is decelerating — 1Y growth trails 5Y average by 24,68%
Capital efficient — spends only 2,43% of revenue on capex
Croissance
Revenue Growth (5Y)
0,96%
Revenue (1Y)-23,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-21,70%
ROIC-8,99%
Net Margin-33,60%
Op. Margin-19,16%
Sécurité
Debt / Equity
0,11
Current Ratio4,55
Interest Coverage0,00
Valorisation
P/E Ratio
-11,68
P/B Ratio2,73
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -23,72% | Revenue Growth (3Y) | -13,82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0,96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 239,44M | Net Income (TTM) | -80,45M |
| ROE | -21,70% | ROA | -17,43% |
| Gross Margin | 73,88% | Operating Margin | -19,16% |
| Net Margin | -33,60% | Free Cash Flow (TTM) | -40,05M |
| ROIC | -8,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 4,55 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,68 | P/B Ratio | 2,73 |
| P/S Ratio | 3,92 | PEG Ratio | -0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 939,26M | Enterprise Value | 824,46M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 239,44M | 313,90M | 322,42M | 284,39M | 230,47M |
| Net Income | -80,45M | -20,21M | 21,35M | 39,67M | 27,51M |
| EPS (Diluted) | -1,62 | -0,41 | 0,43 | 0,80 | 0,50 |
| Gross Profit | 176,90M | 239,58M | 252,65M | 223,38M | 178,64M |
| Operating Income | -45,87M | -12,61M | 28,10M | 43,80M | 33,34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 461,62M | 509,52M | 488,69M | 418,82M | 345,78M |
| Total Liabilities | 117,44M | 112,19M | 102,74M | 82,71M | 87,22M |
| Shareholders' Equity | 344,18M | 397,34M | 385,95M | 336,11M | 258,56M |
| Total Debt | 38,35M | 38,74M | 35,83M | 31,04M | 32,06M |
| Cash & Equivalents | 153,15M | 144,16M | 183,04M | 86,48M | 199,71M |
| Current Assets | 311,55M | 367,94M | 365,27M | 311,72M | 271,41M |
| Current Liabilities | 68,50M | 70,31M | 65,04M | 51,72M | 48,80M |